Jeju National University   Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4
Founded: Jeju City Korea, Republic of (1952)

Organization Overview

First Clinical Trial
2007
NCT00474838
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now

Alternative names

Jeju National University College of Medicine & Jeju National University Hospital | Jeju National University Hospital | Jeju National University School of Medicine | Jeju National Universtiy Hospital of Korea

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Coronary Artery Disease (Phase 4)

Coronary Disease (Phase 4)

Diabetes Mellitus (Phase 4)

Diabetes Mellitus, Type 2 (Phase 4)

Diabetic Neuropathies (Phase 2)

Essential Hypertension (Phase 3)

Gastritis (Phase 3)

Heart Diseases (Phase 4)

Hypertension (Phase 3)

Hypotension (Phase 4)

Myocardial Ischemia (Phase 4)

Neuralgia (Phase 2)

Pancreatic Neoplasms (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 11
  • # of Trial APIs: 17